BioCentury
ARTICLE | Clinical News

Taksta sodium fusidate regulatory update

September 28, 2015 7:00 AM UTC

FDA granted Qualified Infectious Disease Product (QIDP) designation to Taksta sodium fusidate from Cempra to treat acute bacterial skin and skin structure infections (ABSSSI). By year end, Cempra plan...